Cargando…

Four-copy number alteration (CNA)-related lncRNA prognostic signature for liver cancer

The objective of this study was to identify CNA-related lncRNAs that can better evaluate the prognosis of patients with liver cancer. Prognostic molecular subtypes were identified, followed by tumor mutation and differential expression analyses. Genomic copy number anomalies and their association wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Zhenyun, Guo, Yan, Sun, Jingjing, Zheng, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395537/ https://www.ncbi.nlm.nih.gov/pubmed/35995822 http://dx.doi.org/10.1038/s41598-022-17927-0

Ejemplares similares

Pan-cancer driver copy number alterations identified by joint expression/CNA data analysis
por: Wang, Gaojianyong, et al.
Publicado: (2020)

LiquidCNA: Tracking subclonal evolution from longitudinal liquid biopsies using somatic copy number alterations
por: Lakatos, Eszter, et al.
Publicado: (2021)

VCF2CNA: A tool for efficiently detecting copy-number alterations in VCF genotype data and tumor purity
por: Putnam, Daniel K., et al.
Publicado: (2019)

CloneCNA: detecting subclonal somatic copy number alterations in heterogeneous tumor samples from whole-exome sequencing data
por: Yu, Zhenhua, et al.
Publicado: (2016)

Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysis
por: Thiesen, H.-J., et al.
Publicado: (2017)

A four-lncRNA risk signature for prognostic prediction of osteosarcoma
por: Liu, Huanlong, et al.
Publicado: (2023)

seqCNA: an R package for DNA copy number analysis in cancer using high-throughput sequencing
por: Mosen-Ansorena, David, et al.
Publicado: (2014)

LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas
por: Wang, Wen, et al.
Publicado: (2016)

Immune-Related Four-lncRNA Signature for Patients with Cervical Cancer
por: Zheng, Jianfeng, et al.
Publicado: (2020)

Systematic analysis of lncRNA–miRNA–mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer
por: Fan, Chun-Ni, et al.
Publicado: (2018)

Identification of a Four-lncRNA Prognostic Signature for Colon Cancer Based on Genome Instability
por: Yun, Duo, et al.
Publicado: (2021)

Analysis of copy number alterations reveals the lncRNA ALAL-1 as a regulator of lung cancer immune evasion
por: Athie, Alejandro, et al.
Publicado: (2020)

Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data
por: Zhong, Qihang, et al.
Publicado: (2021)

Signatures of copy number alterations in human cancer
por: Steele, Christopher D., et al.
Publicado: (2022)

Identification of a novel four-lncRNA signature as a prognostic indicator in cirrhotic hepatocellular carcinoma
por: Ma, Linkun, et al.
Publicado: (2019)

Impact of CNA on AML prognosis
por: Gonzales, Fanny, et al.
Publicado: (2017)

Identification of the 3-lncRNA Signature as a Prognostic Biomarker for Colorectal Cancer
por: Liu, Shuzhen, et al.
Publicado: (2020)

Six-lncRNA Immune Prognostic Signature for Cervical Cancer
por: Chen, Qian, et al.
Publicado: (2020)

Development of an Immune-Related LncRNA Prognostic Signature for Glioma
por: Cao, Yudong, et al.
Publicado: (2021)

Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
por: Liu, Binfeng, et al.
Publicado: (2022)

The repertoire of copy number alteration signatures in human cancer
por: Tao, Ziyu, et al.
Publicado: (2023)

Comprehensive analysis of a novel four-lncRNA signature as a prognostic biomarker for human gastric cancer
por: Miao, Yan, et al.
Publicado: (2017)

Identification of a TLR-Induced Four-lncRNA Signature as a Novel Prognostic Biomarker in Esophageal Carcinoma
por: Liu, Jing, et al.
Publicado: (2020)

Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration
por: Wang, Zhengguang, et al.
Publicado: (2022)

Establishment of a lncRNA-Based Prognostic Gene Signature Associated With Altered Immune Responses in HCC
por: Li, Xiawei, et al.
Publicado: (2022)

Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma
por: Yin, Zhengrong, et al.
Publicado: (2022)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Identification and validation of immune‐related lncRNA prognostic signatures for melanoma
por: Xiao, Bo, et al.
Publicado: (2021)

The prognostic value of an autophagy-related lncRNA signature in hepatocellular carcinoma
por: Yang, Shiming, et al.
Publicado: (2021)

A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma
por: Zhong, Like, et al.
Publicado: (2023)

Identification of a novel lncRNA prognostic signature and analysis of functional lncRNA AC115619.1 in hepatocellular carcinoma
por: Gan, Binliang, et al.
Publicado: (2023)

A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures
por: Jin, Lipeng, et al.
Publicado: (2020)

A four-lncRNA signature for predicting prognosis of recurrence patients with gastric cancer
por: Chen, Qiang, et al.
Publicado: (2021)

The prognostic value of a seven-lncRNA signature in patients with esophageal squamous cell carcinoma: a lncRNA expression analysis
por: Weng, Nuo-Qing, et al.
Publicado: (2020)

CVAM: CNA Profile Inference of the Spatial Transcriptome Based on the VGAE and HMM
por: Ma, Jian, et al.
Publicado: (2023)

Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma
por: Shi, Xiuhui, et al.
Publicado: (2018)

Identification and validation of stemness-related lncRNA prognostic signature for breast cancer
por: Li, Xiaoying, et al.
Publicado: (2020)

Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Li, Danfeng, et al.
Publicado: (2021)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qmnakbks2mfl5gmeve2j34n2fd